Showing results (1531-1540 of 1,655) with videos related to
Sort By:
Pageof 166
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer GroupMark T Jennings, Richard Sposto, James M Boyett, et al.Brain Pathology (Zurich, Switzerland)|July 28, 2018
The genetic landscape of anaplastic pleomorphic xanthoastrocytomaJoanna J Phillips, Henry Gong, Katharine Chen, et al.Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.Circulation|May 5, 2016
Reproductive Risk Factors and Coronary Heart Disease in the Women's Health Initiative Observational StudyNisha I Parikh, Rebecca P Jeppson, Jeffrey S Berger, et al.Neuro-Oncology|April 12, 2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsJohn H Sampson, Gamal Akabani, Gerald E Archer, et al.Cardiovascular Research|March 24, 2025
Tetraspanin CD37 regulates platelet hyperreactivity and thrombosisMarcin A Sowa, Carmen Hannemann, Ivan Pinos, et al.Neuro-Oncology|June 30, 2026
MAPK-driven glioma progression and reprogramming of the tumor-associated immune responseElaheh Hashemi, Ravishkumar Lakshmi Akshaya, Lin Wang, et al.Oncoimmunology|July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastomaTiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.Journal of Neuro-Oncology|May 21, 2025
Preoperative assessment of tumor eloquence and resectability: an international surveyEmma Rammeloo, Jacob S Young, Joost W Schouten, et al.Lancet (London, England)|January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsJoseph J Eron, Benjamin Young, David A Cooper, et al.Pageof 166